GABARAPL1 and breast carcinoma: It has been reported that Dip G targets the CHIP E3 ubiquitin ligase and reciprocally controls ERα and ERβ protein stability in breast cancer cells, and that GABARAPL1 is identified as an early estrogen-induced gene15,24.